UY25821A1 - Preparaciones de una combinación farmacéutica de carvedilol e hidroclorotiazida - Google Patents
Preparaciones de una combinación farmacéutica de carvedilol e hidroclorotiazidaInfo
- Publication number
- UY25821A1 UY25821A1 UY25821A UY25821A UY25821A1 UY 25821 A1 UY25821 A1 UY 25821A1 UY 25821 A UY25821 A UY 25821A UY 25821 A UY25821 A UY 25821A UY 25821 A1 UY25821 A1 UY 25821A1
- Authority
- UY
- Uruguay
- Prior art keywords
- carvedilol
- pharmaceutical combination
- hydrochlorotiazide
- preparations
- hydrochlorothiazide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una preparación de una combinación farmacéutica para el tratamiento de trastornos cardíacos y cardiovasculares tales como hipertensión, angina de pecho, insuficiencia cardíaca y enfermedades relacionadas, que contiene las substancias activas carvedilol o una sal farmacéuticamente aceptable del mismo e hidroclorotiazida o una sal farmacéuticamente aceptable de la misma, así como aditivos usuales farmacéuticamente. El proceso de producción para la preparación de la combninación, puede comprender los pasos de producción del granulado de carvedilol, de hidroclorotiazida, tratamiento de ambos granulados hasta obtener una masa prensada con una humedad de 6 a20% y una densidad de granel entre 0.1 y 1.5 g/ml
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98122489 | 1998-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY25821A1 true UY25821A1 (es) | 2001-07-31 |
Family
ID=8233041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY25821A UY25821A1 (es) | 1998-11-27 | 1999-11-26 | Preparaciones de una combinación farmacéutica de carvedilol e hidroclorotiazida |
Country Status (22)
Country | Link |
---|---|
US (3) | US6403579B1 (es) |
EP (1) | EP1131072B1 (es) |
JP (2) | JP2002531395A (es) |
KR (1) | KR100421347B1 (es) |
CN (1) | CN1184971C (es) |
AR (1) | AR020287A1 (es) |
AT (1) | ATE238056T1 (es) |
AU (1) | AU765977B2 (es) |
BR (1) | BR9915610A (es) |
CA (1) | CA2352361C (es) |
CO (1) | CO5011053A1 (es) |
DE (1) | DE69907252T2 (es) |
DK (1) | DK1131072T3 (es) |
ES (1) | ES2195638T3 (es) |
MY (1) | MY121831A (es) |
PE (1) | PE20001302A1 (es) |
PT (1) | PT1131072E (es) |
TR (3) | TR200200981T2 (es) |
TW (1) | TWI228414B (es) |
UY (1) | UY25821A1 (es) |
WO (1) | WO2000032174A2 (es) |
ZA (1) | ZA200104280B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
AU2001297631A1 (en) * | 2000-10-24 | 2002-09-04 | Smithkline Beecham Corporation | Novel formulations of carvedilol |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
IN191028B (es) * | 2001-05-17 | 2003-09-13 | Sun Pharmaceutical Ind Ltd | |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
WO2003092622A2 (en) * | 2002-04-30 | 2003-11-13 | Sb Pharmco Puerto Rico Inc. | Carvedilol monocitrate monohydrate |
EP1539140A4 (en) | 2002-06-27 | 2005-12-07 | Sb Pharmco Inc | CARVEDILOLHYDOBROMID |
KR20140006111A (ko) | 2002-06-27 | 2014-01-15 | 스미스클라인 비이참 (코르크) 리미티드 | 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법 |
EP1562552A1 (en) | 2002-11-08 | 2005-08-17 | Egalet A/S | Controlled release carvedilol compositions |
WO2004084868A1 (en) | 2003-03-26 | 2004-10-07 | Egalet A/S | Morphine controlled release system |
EP1615888A1 (en) * | 2003-04-21 | 2006-01-18 | Matrix Laboratories Ltd | Process for the preparation of carvedilol form-ii |
AU2003272851A1 (en) * | 2003-09-26 | 2005-04-14 | Shuyi Zhang | Sustained release preparation containing hydrochlorothiazide |
US20050175695A1 (en) * | 2003-11-25 | 2005-08-11 | Catherine Castan | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
JP2007512372A (ja) | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | カルベジロール塩、対応する組成物、送達および/または治療方法 |
EP1686967A4 (en) * | 2003-11-25 | 2012-08-08 | Smithkline Beecham Cork Ltd | CARVEDILOL-FREE BASE, SALTS, WATER-FREE FORMS OR SOLVATES THEREOF, CORRESPONDING PHARMACEUTICAL COMPOSITIONS, CONTROLLED RELEASE FORMULAS AND TREATMENT OR DISPOSAL PROCEDURES |
DE602004005748T2 (de) * | 2003-12-02 | 2007-12-27 | Nicox S.A., Sophia Antipolis | Nitrooxy-derivate von carvedilol und anderen betablockern als antihypertensiva |
NZ560232A (en) * | 2005-02-25 | 2010-11-26 | Hoffmann La Roche | Tablets with improved drug substance dispersibility |
ATE499090T1 (de) * | 2006-06-16 | 2011-03-15 | Lek Pharmaceuticals | Pharmazeutische zusammensetzung mit hydrochlorothiazid und telmisartan |
GB0612540D0 (en) * | 2006-06-23 | 2006-08-02 | Novartis Ag | Galenical formulations of organic compounds |
WO2008114276A1 (en) * | 2007-03-16 | 2008-09-25 | Lupin Limited | Novel oral controlled release composition of carvedilol |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
AU2010211220B2 (en) | 2009-02-06 | 2013-08-01 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
NZ597283A (en) | 2009-06-24 | 2013-07-26 | Egalet Ltd | Controlled release formulations |
CA2792647A1 (en) * | 2010-03-10 | 2011-09-15 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (de) | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
CZ286723B6 (cs) * | 1991-01-30 | 2000-06-14 | The Wellcome Foundation Limited | Tablety dispergovatelné ve vodě |
ES2106818T3 (es) * | 1991-10-30 | 1997-11-16 | Glaxo Group Ltd | Composicion multicapa que contiene antagonistas de histamina o secotina. |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
FR2752162B1 (fr) * | 1996-08-07 | 1998-11-06 | Jouveinal Lab | Comprime de maleate de trimebutine pellicule |
DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
-
1999
- 1999-11-19 PE PE1999001171A patent/PE20001302A1/es not_active Application Discontinuation
- 1999-11-20 PT PT99957320T patent/PT1131072E/pt unknown
- 1999-11-20 TR TR2002/00981T patent/TR200200981T2/xx unknown
- 1999-11-20 EP EP99957320A patent/EP1131072B1/en not_active Expired - Lifetime
- 1999-11-20 TR TR2001/01470T patent/TR200101470T2/xx unknown
- 1999-11-20 CN CNB998137561A patent/CN1184971C/zh not_active Expired - Lifetime
- 1999-11-20 TR TR2002/00982T patent/TR200200982T2/xx unknown
- 1999-11-20 AT AT99957320T patent/ATE238056T1/de active IP Right Maintenance
- 1999-11-20 ES ES99957320T patent/ES2195638T3/es not_active Expired - Lifetime
- 1999-11-20 WO PCT/EP1999/008972 patent/WO2000032174A2/en active IP Right Grant
- 1999-11-20 AU AU15065/00A patent/AU765977B2/en not_active Expired
- 1999-11-20 CA CA002352361A patent/CA2352361C/en not_active Expired - Lifetime
- 1999-11-20 KR KR10-2001-7006570A patent/KR100421347B1/ko active IP Right Grant
- 1999-11-20 JP JP2000584870A patent/JP2002531395A/ja active Pending
- 1999-11-20 DE DE69907252T patent/DE69907252T2/de not_active Expired - Lifetime
- 1999-11-20 BR BR9915610-5A patent/BR9915610A/pt not_active Application Discontinuation
- 1999-11-20 DK DK99957320T patent/DK1131072T3/da active
- 1999-11-23 US US09/447,872 patent/US6403579B1/en not_active Expired - Lifetime
- 1999-11-24 AR ARP990105974A patent/AR020287A1/es unknown
- 1999-11-25 CO CO99074400A patent/CO5011053A1/es unknown
- 1999-11-25 MY MYPI99005155A patent/MY121831A/en unknown
- 1999-11-26 UY UY25821A patent/UY25821A1/es unknown
-
2000
- 2000-02-23 TW TW089103144A patent/TWI228414B/zh not_active IP Right Cessation
-
2001
- 2001-05-24 ZA ZA200104280A patent/ZA200104280B/xx unknown
- 2001-09-05 US US09/946,205 patent/US20020052367A1/en not_active Abandoned
-
2003
- 2003-10-24 US US10/693,243 patent/US20040087578A1/en not_active Abandoned
-
2006
- 2006-10-19 JP JP2006284476A patent/JP2007077160A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007077160A (ja) | 2007-03-29 |
ES2195638T3 (es) | 2003-12-01 |
WO2000032174A2 (en) | 2000-06-08 |
MY121831A (en) | 2006-02-28 |
WO2000032174A3 (en) | 2000-11-16 |
AU1506500A (en) | 2000-06-19 |
TR200101470T2 (tr) | 2001-11-21 |
PT1131072E (pt) | 2003-08-29 |
KR20010080578A (ko) | 2001-08-22 |
TR200200982T2 (tr) | 2002-06-21 |
DK1131072T3 (da) | 2003-08-11 |
CA2352361C (en) | 2007-01-02 |
ATE238056T1 (de) | 2003-05-15 |
AU765977B2 (en) | 2003-10-09 |
DE69907252T2 (de) | 2004-01-29 |
ZA200104280B (en) | 2002-08-26 |
JP2002531395A (ja) | 2002-09-24 |
CN1328460A (zh) | 2001-12-26 |
AR020287A1 (es) | 2002-05-02 |
BR9915610A (pt) | 2001-08-14 |
EP1131072B1 (en) | 2003-04-23 |
PE20001302A1 (es) | 2000-11-30 |
CN1184971C (zh) | 2005-01-19 |
TR200200981T2 (tr) | 2002-06-21 |
DE69907252D1 (de) | 2003-05-28 |
CO5011053A1 (es) | 2001-02-28 |
TWI228414B (en) | 2005-03-01 |
US20020052367A1 (en) | 2002-05-02 |
CA2352361A1 (en) | 2000-06-08 |
KR100421347B1 (ko) | 2004-03-06 |
EP1131072A2 (en) | 2001-09-12 |
US20040087578A1 (en) | 2004-05-06 |
US6403579B1 (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY25821A1 (es) | Preparaciones de una combinación farmacéutica de carvedilol e hidroclorotiazida | |
RU2640418C2 (ru) | Ингибиторы цистатионин-г-лиазы (cse) | |
HUP0003173A2 (hu) | A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására | |
HUP0302131A2 (hu) | Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények | |
CA2635252A1 (en) | Methods for treating cutaneous lupus using aminoisoindoline compounds | |
AR022085A1 (es) | Una forma de dosificacion farmaceutica de liberacion sostenida y una tableta comprimida | |
DE69620606D1 (de) | Feste oral anzuwendende arzeneiform | |
BR9916224A (pt) | Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola | |
HUP0101246A2 (hu) | Meloxicam új galenusi formulációi orális alkalmazásra és eljárás az előállításukra | |
SK281947B6 (sk) | Použitie farmaceutických preparátov na báze kurkumínu | |
EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
ATE350040T1 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
RU94040864A (ru) | Конденсированные индольные производные, их получение, фармацевтическая композиция | |
KR20150126618A (ko) | 아프레밀라스트를 사용하는 건선성 관절염의 치료 | |
HUP0202671A2 (hu) | Ketotifen optikailag aktív izomerei és aktív metabolitjai | |
ATE243504T1 (de) | Cefadroxilmonohydrat tablettenformulierung | |
ES2208909T3 (es) | Utilizacion de derivados del p-aminofenol para la preparacion de composiciones farmaceuticas utiles en el tratamiento de las enfermedades neurodegenerativas. | |
BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
WO2018094974A1 (zh) | 治疗缺血性脑中风的药物及其制备方法与用途 | |
SE8901003D0 (sv) | Snabbloesliga preparat | |
MX9100246A (es) | Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion | |
HUP0103071A2 (hu) | Citalopramot tartalmazó gyógyászati készítmény | |
FI945313A (fi) | Parannetun biokäytettävyyden omaavat tabletit, jotka sisältävät dikloorimetyleenifosfonihappoa vaikuttavana aineena | |
HUT57204A (en) | Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ABAN | Application deemed to be withdrawn (no publication fee paid) |
Effective date: 20081201 |